Protein microarrays for the detection of biomarkers in head and neck squamous cell carcinomas

Human Pathology

Volumn 38, Issue 2, 2007, Pages 228-238

  Weber, Anette ^a   Hengge, Ulrich R ^b   Stricker, Ingo ^a   Tischoff, Iris ^a   Markwart, Annett ^c   Anhalt, Kathrin ^c   Dietz, Andreas ^a   Wittekind, Christian ^c   Tannapfel, Andrea ^a,c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Biomarker; HNSCC; Protein microarray; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; CYCLOOXYGENASE 2; DNA; HEAT SHOCK PROTEIN 70; MATRILYSIN; ONCOPROTEIN; PESCADILLO PROTEIN; PROTEIN BAG1; PROTEIN C JUN; PROTEIN FOS; PROTEOME; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; THROMBOSPONDIN; TRANSCRIPTION FACTOR FRA 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA MICROARRAY; HEAD AND NECK CANCER; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; STRUCTURAL PROTEOMICS; TISSUE MICROARRAY; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MATRIX METALLOPROTEINASE 7; MULTIVARIATE ANALYSIS; PROTEIN ARRAY ANALYSIS; PROTEOME; REPRODUCIBILITY OF RESULTS; STAT3 TRANSCRIPTION FACTOR; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846240508     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.07.012     Document Type: Article

References (36)

1. Melle C., Ernst G., Schimmel B., et al. A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res 64 (2004) 4099-4104
2. Cho W.C., Yip T.T., Yip C., et al. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res 10 (2004) 43-52
3. Tannapfel A., and Weber A. Tumor markers in squamous cell carcinoma of the head and neck: clinical effectiveness and prognostic value. Eur Arch Otorhinolaryngol 258 (2001) 83-88
4. Wadsworth J.T., Somers K.D., Cazares L.H., et al. Serum protein profiles to identify head and neck cancer. Clin Cancer Res 10 (2004) 1625-1632
5. Lue R.Y., Chen G.Y., Zhu Q., Lesaicherre M.L., and Yao S.Q. Site-specific immobilization of biotinylated proteins for protein microarray analysis. Methods Mol Biol 264 (2004) 85-100
6. Alizadeh A.A., Ross D.T., Perou C.M., and van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195 (2005) 41-52
7. Glokler J., and Angenendt P. Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci 797 (2003) 229-240
8. Zhu H., and Snyder M. Protein chip technology. Curr Opin Chem Biol 7 (2003) 55-63
9. Warren E.N., Elms P.J., Parker C.E., and Borchers C.H. Development of a protein chip: a MS-based method for quantitation of protein expression and modification levels using an immunoaffinity approach. Anal Chem 76 (2004) 4082-4092
10. Angenendt P. Progress in protein and antibody microarray technology. Drug Discov Today 10 (2005) 503-511
11. Tannapfel A., Anhalt K., Hausermann P., et al. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201 (2003) 238-249
12. Sreekumar A., Nyati M.K., Varambally S., et al. Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 61 (2001) 7585-7593
13. Hamilton S.R., and Aaltonen L.A. WHO: pathology and genetics (2000), IARC Press, Lyon
14. Sobin L.H., and Wittekind Ch. U.I.C.C.: TNM classification of malignant tumours. 6th ed. (2002), Wiley-Liss, New York
15. Weber A., Langhanki L., Sommerer F., Markwarth A., Wittekind C., and Tannapfel A. Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 22 (2003) 4757-4759
16. Weber A., Langhanki L., Schutz A., et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 441 (2002) 428-436
17. Robinson W.H., DiGennaro C., Hueber W., et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8 (2002) 295-301
18. Das S., Mandal M., Chakraborti T., Mandal A., and Chakraborti S. Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol Cell Biochem 253 (2003) 31-40
19. Alberti S., Esser C., and Hohfeld J. BAG-1-a nucleotide exchange factor of Hsc70 with multiple cellular functions. Cell Stress Chaperones 8 (2003) 225-231
20. Roepman P., Wessels L.F., Kettelarij N., et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37 (2005) 182-186
21. Warner G.C., Reis P.P., Makitie A.A., et al. Current applications of microarrays in head and neck cancer research. Laryngoscope 114 (2004) 241-248
22. Hasina R., and Lingen M.W. Head and neck cancer: the pursuit of molecular diagnostic markers. Semin Oncol 31 (2004) 718-725
23. Yamashita K., Tanaka Y., Mimori K., Inoue H., and Mori M. Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma. Int J Cancer 110 (2004) 201-207
24. Tanioka Y., Yoshida T., Yagawa T., et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89 (2003) 2116-2121
25. Curran S., Dundas S.R., Buxton J., Leeman M.F., Ramsay R., and Murray G.I. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 10 (2004) 8229-8234
26. Jones L.E., Humphreys M.J., Campbell F., Neoptolemos J.P., and Boyd M.T. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 10 (2004) 2832-2845
27. Thorns V., Walter G.F., and Thorns C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23 (2003) 3937-3944
28. Doucas H., Garcea G., Neal C.P., Manson M.M., and Berry D.P. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41 (2005) 365-379
29. Page V., Cote M., Rancourt C., Sullivan M., and Piche A. BAG-1 p29 protein prevents drug-induced cell death in the presence of EGF and enhances resistance to anoikis in SKOV3 human ovarian cancer cells. Biochem Biophys Res Commun 328 (2005) 874-884
30. Eckhardt B.L., Parker B.S., van Laar R.K., et al. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 3 (2005) 1-13
31. Xi S., Gooding W.E., and Grandis J.R. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. Oncogene 24 (2005) 970-979
32. Nikitakis N.G., Siavash H., and Sauk J.J. Targeting the STAT pathway in head and neck cancer: recent advances and future prospects. Curr Cancer Drug Targets 4 (2004) 637-651
33. Killian A., Le Meur N., Sesboue R., et al. Inactivation of the RRB1-pescadillo pathway involved in ribosome biogenesis induces chromosomal instability. Oncogene 23 (2004) 8597-8602
34. Maiorana A., Tu X., Cheng G., and Baserga R. Role of pescadillo in the transformation and immortalization of mammalian cells. Oncogene 23 (2004) 7116-7124
35. Prisco M., Maiorana A., Guerzoni C., et al. Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells. Mol Cell Biol 24 (2004) 5421-5433
36. Jirtle R.L. IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. Gastroenterology 126 (2004) 1190-1193